13F-HR filed by Eversept Partners, LP
Eversept Partners, LP filed this 13F-HR for the quarter ended 2024-06-30, filed 2024-08-14, with 74 holding rows worth $1,460,284,019.
- Accession
- 0001697013-24-000006
- Filer
- CIK 1697013
- Filed
- 2024-08-14
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q2 2024
A holdings report, 74 entries on the cover page, a total value of $1,460,284,019 stated on the cover page (in dollars after the unit check, H1), rows summing to $1,460,284,019 with VALUE read as dollars as filed, 13F file number 028-18369. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| INVESCO QQQ TR | 46090E103 | COM | 285,600 | $136,833,816 | dollars as filed | put |
| GSK PLC SPONSORED ADR | 37733W204 | ADR | 3,468,080 | $133,521,080 | dollars as filed | |
| NATERA INC COM | 632307104 | Stock | 1,173,494 | $127,077,665 | dollars as filed | |
| INSMED INC COM PAR $.01 | 457669307 | Stock | 1,155,588 | $77,424,396 | dollars as filed | |
| TEVA PHARMACEUTICAL INDS LTD SPONSORED ADS | 881624209 | ADR | 4,720,460 | $76,707,475 | dollars as filed | |
| UNITED THERAPEUTICS CORP DEL COM | 91307C102 | Stock | 235,351 | $74,971,061 | dollars as filed | |
| SYNDAX PHARMACEUTICALS INC | 87164F105 | COM | 3,613,631 | $74,187,844 | dollars as filed | |
| VERA THERAPEUTICS INC | 92337R101 | COMMON STOCK | 2,043,214 | $73,923,483 | dollars as filed | |
| INSPIRE MED SYS INC COM | 457730109 | Stock | 533,011 | $71,332,862 | dollars as filed | |
| REVVITY INC | 714046109 | COM | 451,582 | $47,352,889 | dollars as filed | |
| HCA Healthcare Inc | 40412C101 | COM | 135,480 | $43,527,014 | dollars as filed | |
| BIO-TECHNE CORP | 09073M104 | COM | 543,044 | $38,909,103 | dollars as filed | |
| HEALTHEQUITY INC COM | 42226A107 | Stock | 413,531 | $35,646,372 | dollars as filed | |
| COMMUNITY HEALTH SYSTEMS INC | 203668108 | COMMON STOCK | 8,037,470 | $27,005,899 | dollars as filed | |
| REPLIGEN CORP COM | 759916109 | Stock | 194,291 | $24,492,323 | dollars as filed | |
| CELLDEX THERAPEUTICS INC NEW | 15117B202 | COM NEW | 633,015 | $23,427,885 | dollars as filed | |
| IONIS PHARMACEUTICALS INC COM | 462222100 | Stock | 456,881 | $21,774,948 | dollars as filed | |
| NOVO-NORDISK A S ADR | 670100205 | ADR | 146,956 | $20,976,499 | dollars as filed | |
| Eli Lilly and Company | 532457108 | COM | 21,233 | $19,223,934 | dollars as filed | |
| PROTAGONIST THERAPEUTICS | 74366E102 | COM | 505,836 | $17,527,217 | dollars as filed | |
| SPY | 78462F103 | SHS | 30,800 | $16,761,976 | dollars as filed | put |
| ARGENX SE SPONSORED ADR | 04016X101 | ADR | 34,593 | $14,876,374 | dollars as filed | |
| HUMANA INC COM | 444859102 | Stock | 38,023 | $14,207,294 | dollars as filed | |
| VIATRIS INC COM | 92556V106 | Stock | 1,329,282 | $14,130,268 | dollars as filed | |
| ZIMVIE INC | 98888T107 | COM | 767,659 | $14,009,777 | dollars as filed | |
| MANNKIND CORP COM NEW | 56400P706 | Stock | 2,256,952 | $11,781,289 | dollars as filed | |
| BROOKDALE SR LIVING INC | 112463104 | COM | 1,546,842 | $10,564,931 | dollars as filed | |
| Danaher Corporation | 235851102 | COM | 40,855 | $10,207,622 | dollars as filed | |
| SPDR SER TR | 78464A870 | S&P BIOTECH | 100,000 | $9,271,000 | dollars as filed | |
| TRAVERE THERAPEUTICS INC | 89422G107 | COM | 1,091,165 | $8,969,376 | dollars as filed | |
| Elevance Health, Inc. | 036752103 | COM | 14,657 | $7,942,042 | dollars as filed | |
| ARCUTIS BIOTHERAPEUTICS INC | 03969K108 | COM | 837,847 | $7,791,977 | dollars as filed | |
| CENTENE CORP DEL COM | 15135B101 | Stock | 115,820 | $7,678,866 | dollars as filed | |
| VIRIDIAN THERAPEUTICS INC | 92790C104 | COM | 567,487 | $7,383,006 | dollars as filed | |
| VIKING THERAPEUTICS INC | 92686J106 | COM | 138,489 | $7,341,302 | dollars as filed | |
| VAXCYTE INC COM | 92243G108 | Stock | 96,089 | $7,255,680 | dollars as filed | |
| BIOCRYST PHARMACEUTICALS INC COM | 09058V103 | Stock | 1,152,573 | $7,122,901 | dollars as filed | |
| CYTOKINETICS INC | 23282W605 | COM NEW | 126,877 | $6,874,196 | dollars as filed | |
| NEWAMSTERDAM PHARMA CO NV | N62509109 | COMMON STOCK | 329,890 | $6,337,187 | dollars as filed | |
| EVOLUS INC | 30052C107 | COM | 574,462 | $6,232,913 | dollars as filed | |
| MOLINA HEALTHCARE INC | 60855R100 | COM | 18,277 | $5,433,752 | dollars as filed | |
| SUTRO BIOPHARMA INC | 869367102 | COM | 1,739,129 | $5,095,648 | dollars as filed | |
| GOSSAMER BIO INC COM | 38341P102 | Stock | 5,484,148 | $4,940,669 | dollars as filed | |
| OSCAR HEALTH INC | 687793109 | CL A | 310,893 | $4,918,327 | dollars as filed | |
| CEREVEL THERAPEUTICS HLDNG I | 15678U128 | COM | 110,010 | $4,498,309 | dollars as filed | |
| LIQUIDIA CORPORATION COM NEW | 53635D202 | Stock | 373,554 | $4,482,648 | dollars as filed | |
| MYRIAD GENETICS INC | 62855J104 | COM | 181,961 | $4,450,766 | dollars as filed | |
| PUMA BIOTECHNOLOGY INC | 74587V107 | COMMON STOCK | 1,328,454 | $4,330,760 | dollars as filed | |
| KARYOPHARM THERAPEUTICS INC | 48576U106 | COM | 4,987,180 | $4,326,877 | dollars as filed | |
| 2SEVENTY BIO INC COMMON STOCK | 901384107 | Stock | 1,107,743 | $4,264,811 | dollars as filed | |
| NEVRO CORP | 64157F103 | COM | 499,395 | $4,204,906 | dollars as filed | |
| ICON PUB LTD CO SHS | G4705A100 | Stock | 12,642 | $3,962,888 | dollars as filed | |
| MERUS N V | N5749R100 | COM | 66,474 | $3,933,267 | dollars as filed | |
| MOONLAKE IMMUNOTHERAPEUTICS CLASS A ORD | 61559X104 | Stock | 71,596 | $3,148,076 | dollars as filed | |
| AMARIN CORP PLC | 023111206 | SPONS ADR NEW | 4,308,527 | $2,964,267 | dollars as filed | |
| GUARDANT HEALTH INC COM | 40131M109 | Stock | 99,377 | $2,870,008 | dollars as filed | |
| Inflarx Nv | N44821101 | COM | 1,566,930 | $2,726,458 | dollars as filed | |
| AVANTOR INC COM | 05352A100 | Stock | 125,394 | $2,658,353 | dollars as filed | |
| Tourmaline Bio Inc | 89157D105 | Common Stock | 204,781 | $2,633,484 | dollars as filed | |
| IQVIA HLDGS INC COM | 46266C105 | Stock | 12,178 | $2,574,916 | dollars as filed | |
| ALECTOR INC | 014442107 | COMMON STOCK | 541,739 | $2,459,495 | dollars as filed | |
| IMMUNOVANT INC | 45258J102 | COM | 92,909 | $2,452,798 | dollars as filed | |
| XOMA ROYALTY CORPORATION | 98419J206 | COMMON STOCK | 91,907 | $2,177,277 | dollars as filed | |
| AUTOLUS THERAPEUTICS PLC SPON | 05280R100 | COM | 610,902 | $2,125,939 | dollars as filed | |
| TERNS PHARMACEUTICALS INC COM | 880881107 | Stock | 286,266 | $1,949,471 | dollars as filed | |
| MEREO BIOPHARMA GROUP PLC | 589492107 | CMN | 496,171 | $1,786,216 | dollars as filed | |
| KURA ONCOLOGY INC COM | 50127T109 | Stock | 72,317 | $1,489,007 | dollars as filed | |
| ABSCI CORPORATION | 00091E109 | COM | 325,509 | $1,002,568 | dollars as filed | |
| FULCRUM THERAPEUTICS INC | 359616109 | COMMON STOCK | 152,965 | $948,383 | dollars as filed | |
| AFFIMED N V | N01045207 | COM | 166,460 | $907,207 | dollars as filed | |
| STOKE THERAPEUTICS INC | 86150R107 | COM | 61,277 | $827,852 | dollars as filed | |
| G1 THERAPEUTICS INC | 3621LQ109 | COM | 199,963 | $455,916 | dollars as filed | |
| AC IMMUNE SA | H00263105 | SHS | 99,313 | $396,259 | dollars as filed | |
| SERES THERAPEUTICS INC | 81750R102 | COM | 418,208 | $302,699 | dollars as filed |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001697013-24-000006 | this filing | 2024-08-14 | acceptance time not in the bulk data set |